{"doi":"10.1097/tp.0b013e3181ff87cd","title":"Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT Studies","abstract":null,"journal":"Transplantation","year":2010,"id":18024,"datarank":6.968983471015532,"base_score":5.147494476813453,"endowment":5.147494476813453,"self_citation_contribution":0.7721241715220181,"citation_network_contribution":6.196859299493514,"self_endowment_contribution":0.7721241715220181,"citer_contribution":6.196859299493514,"corpus_percentile":null,"corpus_rank":null,"citation_count":171,"citer_count":143,"citers_with_citation_signal":116,"citers_with_endowment":116,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":126773,"name":"Josep Grinyó","orcid":null,"position":1,"is_corresponding":false},{"id":126774,"name":"José Medina-Pestana","orcid":null,"position":2,"is_corresponding":false},{"id":126775,"name":"Yves Vanrenterghem","orcid":null,"position":3,"is_corresponding":false},{"id":126505,"name":"Flavio Vincenti","orcid":null,"position":4,"is_corresponding":false},{"id":126776,"name":"Barbara Breshahan","orcid":null,"position":5,"is_corresponding":false},{"id":126777,"name":"Josep M. Campistol","orcid":null,"position":6,"is_corresponding":false},{"id":126778,"name":"Sander Florman","orcid":null,"position":7,"is_corresponding":false},{"id":126779,"name":"Maria del Carmen Rial","orcid":null,"position":8,"is_corresponding":false},{"id":126780,"name":"Nassim Kamar","orcid":null,"position":9,"is_corresponding":false},{"id":126781,"name":"Alan Block","orcid":null,"position":10,"is_corresponding":false},{"id":126782,"name":"Gregory Di Russo","orcid":null,"position":11,"is_corresponding":false},{"id":126783,"name":"Chen-Sheng Lin","orcid":null,"position":12,"is_corresponding":false},{"id":126784,"name":"Pushkal Garg","orcid":null,"position":13,"is_corresponding":false},{"id":126785,"name":"Bernard Charpentier","orcid":null,"position":14,"is_corresponding":false},{"id":126517,"name":"Christian P. Larsen","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":5.147494476813453,"endowment":5.147494476813453,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"21076381","pmcid":null,"openalex_id":"https://openalex.org/W1973505502","authors":[],"funders":[],"total_grants":0,"fwci":12.9846,"citation_percentile":0.99199126,"influential_citations":6,"citation_trend":[{"year":2012,"count":36},{"year":2013,"count":20},{"year":2014,"count":23},{"year":2015,"count":16},{"year":2016,"count":10},{"year":2017,"count":7},{"year":2018,"count":4},{"year":2019,"count":6},{"year":2020,"count":2},{"year":2021,"count":5},{"year":2022,"count":5},{"year":2023,"count":5},{"year":2024,"count":5},{"year":2025,"count":7},{"year":2026,"count":1}],"oa_status":"closed","license":null,"oa_locations":[{"url":"https://journals.lww.com/transplantjournal/Fulltext/2010/12270/Belatacept_Based_Regimens_Versus_a_Cyclosporine.46.aspx","host_type":"BRONZE"},{"url":"http://journals.lww.com/00007890-201012270-00046","host_type":"publisher"},{"url":"https://doi.org/10.1097/tp.0b013e3181ff87cd","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/21076381","host_type":"repository"},{"url":"http://repositorio.unifesp.br/handle/11600/33174","host_type":"repository"}],"fields_of_study":["Renal Transplantation Outcomes and Treatments","Complement system in diseases","Renal Diseases and Glomerulopathies","Medicine","Abatacept","Cyclosporine","Follow-Up Studies","Graft Survival","Humans","Immunoconjugates","Immunosuppressive Agents","Kidney Function Tests","Kidney Transplantation","Lymphoproliferative Disorders","Postoperative Complications","Risk Assessment","Survival Rate","Time Factors","Treatment Outcome"],"mesh_terms":["Abatacept","Follow-Up Studies","Graft Survival","Humans","Immunosuppressive Agents","Kidney Function Tests","Lymphoproliferative Disorders","Postoperative Complications","Time Factors","Survival Rate","Kidney Transplantation","Cyclosporine","Treatment Outcome","Risk Assessment","Immunoconjugates"],"keywords":["Belatacept","Regimen","Kidney transplant","Medicine","Kidney transplantation","Oncology","Internal medicine","Kidney"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-03T04:30:52.476146Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}